Stocks and Investing Stocks and Investing
Thu, June 11, 2020
Wed, June 10, 2020
Tue, June 9, 2020
Mon, June 8, 2020
Fri, June 5, 2020

Matthew Luchini Initiated (VKTX) at Buy and Held Target at $14 on, Jun 5th, 2020


Published on 2024-10-27 07:45:18 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "Viking Therapeutics, Inc." (VKTX) at Buy and Held Target at $14 on, Jun 5th, 2020.

Matthew has made no other calls on VKTX in the last 4 months.



There are 3 other peers that have a rating on VKTX. Out of the 3 peers that are also analyzing VKTX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Michael Morabito of "Chardan Capital" Initiated at Strong Buy and Held Target at $15 on, Tuesday, May 5th, 2020
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $25 on, Friday, May 1st, 2020
  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $18 on, Thursday, February 27th, 2020